Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...

Economists created an index to measure economic-policy uncertainty. President Donald Trump’s tariff onslaught has put it in ...

Gamers got a classic “good news, bad news” announcement on Good Friday.

Nvidia and Alphabet are among the tech stocks that garner mostly bullish ratings from analysts — and have high upside to the ...